Scientists Find DMT Produces a Waking Dream State

Scientists Find DMT Produces a Waking Dream State

Since the beginning of humanity, dreams have played an important role in spirituality, with shamans and sages interpreting them for their deeper meaning. In modern times, Freud and Jung have brought dream study to a new level, exploring the relationship of dreams to the subconscious and unconscious, looking for ways that a deeper self tries to communicate with the conscious one. And now, we’ve come to an even greater look at dreams via the influence of natural plants that contain what has been termed “the spirit molecule” — DMT (dimethyltryptamine). Researchers are now studying DMT’s ability to actually create a type of waking dream.

DMT is well known to neuroscientists, avid users of hallucinogenic plants, and ethnobotanists. The DMT compound produces brief and intense visual and auditory hallucinogenic experiences, whether consumed through ayahuasca, or as an isolated chemical — a white crystalline powder derived from plants found in Mexico, South America, and parts of Asia.

Medical News Today reported that the chemical root structure of DMT acts as a non-selective agonist (a substance that initiates a physiological response when combined with a receptor) at most or all serotonin receptors in the body’s cells. Serotonin has been called the happy chemical because it contributes to wellbeing and happiness. DMT is also produced naturally in the body in the lungs and in minute doses in certain areas of the brain.

DMT: Revolution of Consciousness

DMT Study and the Dream State

After untold generations of ayahuasca use, science has now begun to take a closer look into its brews in the context of its most active ingredient, dimethyltryptamine. The DMT study is the first to show how DMT changes waking brain waves in such a way that researchers have begun comparing its effects to dreaming while awake.

The Psychedelic Research team at London’s Imperial College, headed up a DMT study to examine transitions in and out of the altered state of consciousness caused by intravenous administration of a fast-acting form of DMT. They explained, “the phenomenology of the DMT experience suggests it may be an especially powerful scientific tool for illuminating the neurobiology of consciousness. DMT experiences can be said to resemble ‘world-analog’ experiences (i.e. interior analogs of external worlds) – similar to the dream state.” 

As a result of their DMT study, the team concluded that, at high doses, the effects of DMT lead rapidly into a deep and profound immersion, sometimes described as a “breakthrough.” This experience is often described as a sense of entering into another, but completely real, world or dimension. Users commonly describe encounters with sentient “entities” or “presences” within this other world. The experience often challenges beliefs about the nature of reality and consciousness.

DMT Effects on Brain Activity

The Imperial College research team captured EEG (electrical brain activity) measures from 13 healthy participants who were given an intravenous infusion of DMT. Volunteers were fitted with electrodes in their caps to measure electrical activity before, during, and after their infusion. The analysis revealed that DMT significantly altered electrical activity in the brain, characterized by a marked drop off in beta waves – the human brain’s dominant electrical rhythm when a person is awake. Most significantly, researchers found a short-lived increase in brainwaves typically associated with dreaming — namely, theta waves.

In addition to changes in the types of brainwaves, the researchers also found that, overall, brain activity on DMT became more chaotic and less predictable. This is the opposite of what is seen in states of reduced consciousness, such as in deep sleep or under general anesthesia.

“The changes in brain activity that accompany DMT are slightly different from what we see with other psychedelics, such as psilocybin or LSD, where we see mainly only reductions in brainwaves,” the researchers said.

Ayahuasca DMT and Jungle Magic

Called the “vine of the soul,” ayahuasca is made of the Banisteriopsis caapi vine and the shrub Psychotria viridis (known as “chacruna”), which contains the primary psychoactive, DMT, as well as the plants Diplopterys cabrerana (also known as “chaliponga” and “chacropanga”) and Mimosa tenuiflora. At some point in history, perhaps because the jungle spirits called them to sacred places along the Amazon basin, shamans discovered that the ayahuasca vine needed these other plants to activate the DMT components in the body. 

Making the ayahuasca brew is a ritual that begins with a shaman picking the lower chacruna leaf at sunrise, followed by a prayer. The vine is not just washed, but it is cleansed with wooden spoons and then pounded with wooden mallets until it turns to fiber. 

Ayahuasca is no casual hallucinogen. Devotees and shamans of the Amazon teach that it needs to be treated with profound respect, and they regard the brew as a holy goddess. It is treated as a being, a soul of the Amazon jungle, who confers upon its users an experience of the divine and insight into the core of one’s being. 

Ethnopharmacologist Dennis McKenna, younger brother of the famed ethnobotanist Terrance McKenna, said, “With ayahuasca, it’s often said that you should have a goal going into it and state your intentions. I used to emphasize that myself, but I’ve sort of come around in some ways. If you have an intention going into it, that’s fine. If there’s something that you really want to get some insight about then ok, do that. But my own preference lately has been to approach it with very little structured intent. I tend to say ‘Tell me what I need to know, tell me something that you want me to know,’ and that’s how I approach it.”

Science Proves What Is Already Known

While it may be obvious to centuries of shamans that DMT-containing plants bring the dream world into waking consciousness, science has lagged behind. The latest research merely confirms what has been experienced in all corners of the world. Unfortunately, the DMT spirit molecule remains a Schedule I controlled substance in the United States. Proponents of ayahuasca, magic mushrooms and other mind-expanding plants argue that it’s time to embrace what nature has provided to bring more insight and compassion into our lives. Author and ayahuasca user Graham Hancock questioned, “Why should it be the case that society is afraid of realizing human potential?”

New Studies Find Psychedelics Highly Effective for Alcoholism

New studies show unprecedented success in the treatment of alcoholism with psychedelic therapy.

The psychedelic revolution in mental health has produced overwhelming scientific evidence demonstrating the great efficacy of psychedelics in the treatment of various mental health disorders. Now, several new studies involving the drugs ketamine and MDMA are showing significant promise in the treatment of alcoholism.

Dr. Ben Sessa is a psychiatrist and chief medical officer at Awakn Life Sciences, an English biotech company that is at the forefront of the research, development, and delivery of psychedelic medicines.

The company is especially focused on the treatment of Alcohol Use Disorder or AUD, given how prevalent and challenging it is to treat.

“Alcoholism is a huge public health problem. It’s also a psychiatric condition that’s very poorly treated with very poor outcomes with traditional methods,” Sessa said. “Relapse to drinking after getting dry is around 80 to 90 percent at 12 months. That’s an embarrassingly poor statistic. Psychedelics offer a completely new approach; they offer the patient to explore the root causes of addiction, which so often is trauma. Psychedelic-assisted psychotherapy is an intensive upfront piece of work that gets the patient better, so they don’t have to keep coming back. It is a completely different paradigm shift to the way we currently manage patients in maintenance therapies.” 

A recent study conducted by researchers at the University of Exeter and Awakn Life Sciences is the world’s first to examine the use of ketamine to treat AUD in a randomized controlled trial.

“Ketamine is a very well-established human medicine. It is indeed the only psychedelic that’s licensed as a medicine, as an anesthetic medicine, and has been used since the 60s as such. It’s an incredibly safe medicine. When it’s used at a much lower dose, it produces an altered state of consciousness. What we do in psychedelic-assisted psychotherapy with ketamine, is we use this altered state of consciousness to affect a more effective and deeper form of psychotherapy. So, we’re using ketamine as an adjunct to psychotherapy to treat addictions,” he said.  

Read Article

Our unique blend of yoga, meditation, personal transformation, and alternative healing content is designed for those seeking to not just enhance their physical, spiritual, and intellectual capabilities, but to fuse them in the knowledge that the whole is always greater than the sum of its parts.


Use the same account and membership for TV, desktop, and all mobile devices. Plus you can download videos to your device to watch offline later.

Desktop, laptop, tablet, phone devices with Gaia content on screens
Testing message will be here